News
TWST
70.06
+0.03%
0.02
Cathie Wood’s Ark Invest buys tech dip led by NVDA, AVGO, GOOG, META, dumps AMD
Seeking Alpha · 1d ago
Weekly Report: what happened at TWST last week (0601-0605)?
Weekly Report · 1d ago
Twist Bioscience's Chief Legal Officer Sold Over 14,000 Company Shares. What Does That Mean for Investors?
The Motley Fool · 3d ago
Twist Biosciences' (TWST) CEO Sold 16,000 Shares for $1.1 Million
NASDAQ · 5d ago
Most and least shorted mid- to mega-cap healthcare stocks at the end of May
Seeking Alpha · 6d ago
Twist Bioscience Chief Legal Officer Dennis Cho sells 14,205 shares worth $990,798.75
PUBT · 06/02 20:07
Twist Bioscience CFO Adam Laponis disposes of 4,000 shares worth $280,000
PUBT · 06/02 20:06
A Look At Twist Bioscience (TWST) Valuation After A Strong Multi Year Share Price Run
Simply Wall St · 06/02 17:24
3 Promising Genomics & Synthetic Biology Stocks in Spotlight in 2026
NASDAQ · 06/02 16:09
Twist Bioscience posts investor presentation on DNA synthesis platform, growth strategy
PUBT · 06/02 15:16
Twist Bioscience director Melissa A. Starovasnik sells 2,500 shares for $170,000
PUBT · 06/01 20:07
Twist Bioscience CEO Emily Leproust disposes of 16,470 shares worth $1,113,147.49
PUBT · 06/01 20:07
Cathie Wood’s weekly recap: Heavy buying in Kratos Defense and Cerebras funded by sharp trims in Robinhood and Teradyne
Seeking Alpha · 06/01 11:00
Weekly Report: what happened at TWST last week (0525-0529)?
Weekly Report · 06/01 10:21
Twist Bioscience director Melissa A. Starovasnik disposes of 500 common shares for $30,520
PUBT · 05/28 20:07
Twist Bioscience CEO Emily Leproust sells 49,299 shares for $3.22 million
PUBT · 05/28 20:06
Oppenheimer unveils the best SMID buy and sell ideas across every major sector
Seeking Alpha · 05/26 15:18
Twist Bioscience Earns Buy Rating on AI-Driven Demand, Factory-of-the-Future Capacity and Path to EBITDA Breakeven
TipRanks · 05/26 09:15
Barclays Remains a Buy on Twist Bioscience (TWST)
TipRanks · 05/26 08:56
Cathie Wood’s weekly update: Heavy buying in Bullish and Cerebras funded by sharp trims in Roku and AMD
Seeking Alpha · 05/25 11:00
More
Webull provides a variety of real-time TWST stock news. You can receive the latest news about Twist Bioscience through multiple platforms. This information may help you make smarter investment decisions.
About TWST
Twist Bioscience Corporation provides customizable solutions across the biological continuum that enable scientific discovery and development across therapeutics, diagnostics, and other high-growth markets. The Company's proprietary silicon-based platform delivers precision, scale, and speed, supporting consistent, high-quality performance across a range of applications. The Company’s platform is a differentiated method of manufacturing synthetic deoxyribonucleic acid (DNA) by writing DNA on a silicon chip. By integrating proprietary hardware, software, and scalable infrastructure, including its e-commerce platform. The Company has extended this platform beyond DNA synthesis to offer an integrated portfolio that includes synthetic genes, next-generation sequencing, applications, sample preparation tools, antibody libraries, and biologic discovery services. Leveraging the same platform, it also manufactures synthetic ribonucleic acid (RNA) and expresses antibody proteins.